echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nature's new study answers the controversy: embryonic blood cells are not dependent on stem cells

    Nature's new study answers the controversy: embryonic blood cells are not dependent on stem cells

    • Last Update: 2022-10-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
       

       

    Figure: (Left) In the Standard Model, hematopoietic progenitor cells are produced
    from hematopoietic stem cells.
    (Right) In the proposed model, hematopoietic stem cells and progenitor cells are produced independently of prehematopoietic stem cells and progenitor cell (pre-HSPC) populations
    .

    The fetal liver is the main hematopoietic organ
    at the embryonic stage.
    It is generally believed that the hematopoietic grade of the fetal liver is established through the differentiation of fetal hematopoietic stem cells (HSCs
    ).
    This view holds that the relationship between hematopoietic stem cells and progenitor cells of
    the offspring is conserved from embryo to adulthood.
    A collaborative study by Kumamoto University in Japan found that through lineage tracing and hematopoietic stem cell depletion of mutant mice, most hematopoietic progenitor cells came directly from precursor cells rather than hematopoietic stem cells
    .
    In addition, lineage tracking also showed that fetal hematopoietic stem cells have little effect on progenitor cells before birth
    .
    The researchers believe that most blood cells in embryos are not dependent on hematopoietic stem cells, prompting a reconsideration of the role of
    stem cells in embryonic formation.

    In terms of hematopoietic system formation, the researchers also solved a long-standing problem, namely the origin
    of hematopoietic stem cells.

    Previous transplantation experiments combined with in vitro culture have proposed that hematopoietic stem cells are mainly produced in the aorta-gonadis-midrenal region
    of the embryo.
    However, this finding has been controversial
    due to the lack of clear molecules and molecular structures.
    Now, for the first time, researchers have shown that the transcription factor Evi1 is specifically expressed in the intraembryonic arteries and that it is a necessary and sufficient condition for
    hematopoietic stem cell production.

    Until now, no method
    has been established to specifically produce hematopoietic stem cells from iPS/ES cells.
    Therefore, there is a need to have a clear understanding of the formation of hematopoietic stem cells and embryonic hematopoietic systems to promote the further development
    of regenerative medicine.
    The results of this study provide important evidence
    for improving culture systems for clinically relevant hematopoietic stem cells.

    "We know why hematopoietic stem cells are so difficult to produce," Dr.
    Yokomizo said
    .
    "Our work suggests that the expression of Evi1 may be a good indicator
    of inducing them in vitro.
    "

    Hematopoietic stem cells are important
    in fighting many blood and immune diseases.
    Dr.
    Yokomizo and his team are trying to make it easier
    to make hematopoietic stem cells for transplantation in the lab.
    Currently, they are studying how hematopoietic stem cells are produced
    before birth.


    essay

    Independent origins of fetal liver hematopoietic stem and progenitor cells

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.